FDA Adverse Event Malfunction Summary report: N

ENDOTAK ENDURANCE

MDR report key: 3212680 · Received July 9, 2013

Report

Report Number
2124215-2013-10075
Event Type
Malfunction
Date Received
July 9, 2013
Date of Event
May 30, 2013
Report Date
October 8, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE TECHNICAL SERVICES CONSULTANT RECOMMENDED A LEAD REVISION. IT WAS LATER REPORTED THAT THE PATIENT WAS ADMITTED TO THE HOSPITAL PENDING A LEAD REPLACEMENT PROCEDURE. BEFORE THE PROCEDURE, THE PHYSICIAN PERFORMED A SUBCLAVIAN VENOGRAM THAT REVEALED AN OCCLUSION. THE PATIENT WAS RESCHEDULED FOR A LEAD EXTRACTION AND IMPLANT OF A NEW SYSTEM ON THE RIGHT SIDE IN TWO WEEKS. THIS INVESTIGATION WILL BE UPDATED WHEN FURTHER INFORMATION REGARDING THE SCHEDULED PROCEDURE IS PROVIDED.

Additional Manufacturer Narrative · 1

BOSTON SCIENTIFIC RECEIVED ADDITIONAL INFORMATION THAT THIS LEAD REMAINS IN SERVICE. THE PATIENT AND LEAD CONTINUE TO BE MONITORED WITH THE PATIENT'S HOME REMOTE MONITORING SYSTEM. A LEAD REVISION WAS STILL INTENDED, BUT HAS NOT BEEN SCHEDULED OR PERFORMED. THIS REPORT WILL BE UPDATED SHOULD FURTHER INFORMATION BE RECEIVED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED NOISE THAT WAS OVERSENSED, CAUSING SOME PACING TO BE INHIBITED. A TECHNICAL SERVICES CONSULTANT REVIEWED STORED ELECTROGRAMS AND DISCUSSED THE NOISE WAS MECHANICAL IN APPEARANCE, CONSISTENT WITH A LEAD FRACTURE. THE PATIENT WAS NOT SYMPTOMATIC DURING THE EPISODES. THE NOISE COULD NOT BE REPRODUCED, AND AN X-RAY DID NOT REVEAL ANY LEAD ANOMALIES. RV SENSITIVITY WAS DECREASED IN THE DEVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

--

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
313077 ENDOTAK ENDURANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0145

Patients

Seq Age Sex Outcome Treatment
1 83 YR 1793| T177| 0145| E102